Skip to content

Kyverna Therapeutics, Inc. KYTX Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Gilead Sciences logo
Gilead SciencesGILD
$172.99B+23.8%
Climb Bio, Inc. logo
Climb Bio, Inc.CLYM
$327.21M+297%
Artiva Biotherapeutics, Inc. logo
Artiva Biotherapeutics, Inc.ARTV
$159.18M+118%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$1.45B+32.4%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$2B+82.0%

Other financials

Income statement

See full
Operating income-$41.4M+12.7%
Net income-$39.7M+11.0%
EPS (diluted)-$0.66+35.9%

Balance sheet

See full
Cash & equivalents$32.2M-43.4%
Total debt$9.2M+32.1%
Total equity$195.6M-12.7%
Total assets$257.0M-1.4%

Cash flow

See full
Operating cash flow-$41.6M+7.4%
CapEx$2.0K-98.0%
Free cash flow-$33.5M+10.8%

Valuation

See full
Enterprise value$475.49M+475%

Returns & leverage

See full
Return on equity-74.5%+74.4pp
Debt / equity0.0×
Current ratio8.1×+0.7×

Where this comes from

Computed from the period-end share price: $521.73M.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s market capitalization?
Kyverna Therapeutics, Inc. (KYTX) reported market capitalization of $521.73M in Q1 2026.
How has Kyverna Therapeutics, Inc.'s market capitalization changed year-over-year?
Kyverna Therapeutics, Inc.'s market capitalization increased by 526.2% year-over-year, from $83.32M to $521.73M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.